Oncology

Carfilzomib

CategoryOncology
CAS868540-17-4
SpecificationIn-house
US DMFN/A
CEP/EDMFN/A
GMP CertificationN/A
InspectionN/A
StatusDevelopment
Major Market & RegulationUSA, EU and Japan Market